Angioedema: all 69 studies
Page 1 of 1. Open to participants first (16), then studies with results posted, then the rest; newest registration first within each.
- EAP for Deucrictibant Immediate-releaseAvailableNCT07759141
- Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor DeficiencyRecruitingNCT07266805Phase 3
- A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaEnrolling by invitationNCT07204938Phase 3
- Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema PatientsRecruitingNCT07046806Phase 1/2
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT07021495
- A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)RecruitingNCT07001280
- Lanadelumab in Long-term Prophylaxis of Acquired AngioedemaRecruitingNCT06818474Phase 4
- ScATtEred Rare Disease Biobanks: a Model of Sample/Data Collection With susTainablE and Shared CriteriaRecruitingNCT06782230
- Safety and Efficacy of Conestat Alfa for ACE-Induced AngioedemaNot yet recruitingNCT06679426Phase 3
- Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema AttacksRecruitingNCT06361537Phase 3
- Angioedema Biomarker Research StudyRecruitingNCT06210698
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT05904301
- Allergy and Immunology Natural History StudyRecruitingNCT05584488
- Lanadelumab in Bradykinin AngioedemaRecruitingNCT04597944
- Deployment o the Multidisciplinary Prospective Cohort ImminentRecruitingNCT04334031Not applicable
- CLOUD-R HAE REGISTRYRecruitingNCT03845946
- Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous UrticariaCompletedNCT05936567Phase 2Results posted
- A Study of Navenibart (STAR-0215) in Participants With Hereditary AngioedemaCompletedNCT05695248Phase 1/2Results posted
- Treatment of Angiotensin Converting Enzyme Inhibitor-induced AngioedemaTerminatedNCT04679311Phase 2Results posted
- A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-InhibitorCompletedNCT04444895Phase 3Results posted
- A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)CompletedNCT04206605Phase 3Results posted
- Mepolizumab in Episodic Angioedema With EosinophiliaTerminatedNCT04128371Phase 2Results posted
- A Safety Study For Prevenar 13 Among Chinese ChildrenCompletedNCT03656939Results posted
- Treatment of Idiopathic Angioedema With Xolair as Add-on TherapyCompletedNCT02966314Phase 4Results posted
- OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) PatientsCompletedNCT02161562Phase 3Results posted
- Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese VolunteersCompletedNCT02045264Phase 1Results posted
- Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced AngioedemaCompletedNCT01919801Phase 3Results posted
- Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to TherapyCompletedNCT01723072Phase 3Results posted
- Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated AngioedemaTerminatedNCT01574248Phase 4Results posted
- The Role of Vitamin D in Chronic Urticaria and Angioedema TreatmentCompletedNCT01371877Not applicableResults posted
- Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) PatientsCompletedNCT01359969Phase 2Results posted
- Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced AngioedemaTerminatedNCT01343823Phase 2Results posted
- Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE AttacksCompletedNCT01188564Phase 3Results posted
- A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic AnaphylaxisCompletedNCT00890162Phase 2Results posted
- Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary AngioedemaCompletedNCT00262301Phase 3Results posted
- Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary AngioedemaCompletedNCT00225147Phase 2/3Results posted
- Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary AngioedemaCompletedNCT00097695Phase 3Results posted
- A Single-Arm Exploratory Study of NatureU Hista Dissolve on Chronic Urticaria SymptomsCompletedNCT07611032Not applicable
- A Study of Navenibart in Participants With Hereditary AngioedemaActive, not recruitingNCT06842823Phase 3
- Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency DepartmentCompletedNCT06096077
- A Long-term Study of STAR-0215 in Participants With Hereditary AngioedemaActive, not recruitingNCT06007677Phase 2
- A Study to Review the Treatment and Outcomes of Teenagers and Adults With Non-histaminergic Angioedema With Normal C1 Inhibitor in CanadaCompletedNCT05578417
- A Study of STAR-0215 in Healthy Adult ParticipantsCompletedNCT05477160Phase 1
- Characterization of Rhythmicity Profiles of Bradykinin-mediated Angioedema Attacks Using a Tracking Smartphone Application.WithdrawnNCT05304091
- Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin AngioedemaTerminatedNCT04963634
- Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary AngioedemaWithdrawnNCT04898309Phase 2/3
- Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and AdultsNo longer availableNCT04583007
- Safety and Pharmacokinetics of GNR-038 in Healthy VolunteersCompletedNCT04557319Phase 1
- Involvement of Monocytic B1 and B2 Receptors in Inflammation and Chronic Vascular Disease in Patients With Hereditary Bradykinetic AngioedemaCompletedNCT04032002Not applicable
- Evaluation of New Markers in Type 3 AngioedemaCompletedNCT03917680Not applicable
- Global Registry to Gather Data on Natural History of Patients With Hereditary Angioedema Type I and IIStatus unknownNCT03828279
- Dupilumab in Chronic Spontaneous UrticariaCompletedNCT03749135Phase 2
- Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)CompletedNCT03240991
- Biomarker for Hereditary AngioEdema DiseaseCompletedNCT03029728
- Determination of Specific Biomarkers of Angioneurotic CrisisCompletedNCT02833675
- Analysis of the Availability of the Treatments for ACE-I and ARB-induced AngioedemaCompletedNCT02826356
- Randomized, Double-blind, Two Arms, Multicenter, Phase III Study of Berinert for Treatment of ACE Induced AngioedemaCompletedNCT01843530Phase 3
- C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) AttacksCompletedNCT01397864
- AMelioration of Angiotensin Converting Enzyme Inhibitor Induced Angioedema StudyCompletedNCT01154361Phase 2
- C1-INH Compared to Placebo at the Time of Prodromal Symptoms for Hereditary Angioedema (HAE) ExacerbationWithdrawnNCT01151735Phase 4
- Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced AngioedemaStatus unknownNCT01036659Phase 2
- Vitamin D Levels in Subjects With Chronic Urticaria and AngioedemaCompletedNCT00876369
- Bradykinin Receptor Blocker in ACE Inhibitor-associated AngioedemaTerminatedNCT00517582Phase 1
- Significance of an Elimination and Provocation Diet in Patients With Chronic UrticariaCompletedNCT00385372Not applicable
- The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or AngioedemaStatus unknownNCT00163839Not applicable
- C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) AngioedemaCompletedNCT00125541Phase 2/3
- C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) AngioedemaCompletedNCT00125151Phase 3
- Kinetics, Efficacy and Safety of C1-Esteraseremmer-NCompletedNCT00119431Phase 2
- Study of Heparin Prophylaxis of Hereditary Angioedema ExacerbationsCompletedNCT00004694Not applicable